Immunai, BCM developing first-in-human cell therapy for neuroblastoma
Immunai CEO Noam Solomon: “We keep growing Immunai and strengthening the platform.”
Source: jpost.com
Stay updated with breaking news from Leonid Matelista. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Immunai CEO Noam Solomon: “We keep growing Immunai and strengthening the platform.”